Myopia Completed Phase 3 Trials for Verteporfin (DB00460)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00967850Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High MyopiaTreatment